Key result
Bepridil significantly suppressed the inducibility of atrial fibrillation during vagal nerve stimulation, reducing induction from 100% (9 of 9) to 33% (3 of 9) of experiments (P<0.01).
Why the study?
Does bepridil reduce atrial fibrillation inducibility during vagal nerve stimulation in a canine model?
Does bepridil reduce atrial fibrillation inducibility during vagal nerve stimulation in a canine model?
Bepridil prevents vagal nerve stimulation-induced shortening of atrial action potential duration and suppresses atrial fibrillation inducibility in a canine model, likely via I(KAch) inhibition.
Bepridil effects in this canine model are hypothesis-generating; human trials needed before any clinical consideration.
BACKGROUND: Because bepridil blocks multiple myocardial ionic channels, including the muscarinic acetylcholine receptor-operated potassium current (I(KAch)), bepridil is expected to suppress atrial fibrillation (AF) mediated by vagal nerve stimulation (VNS). METHODS AND RESULTS: The therapeutic effects of bepridil were studied with a special focus on heart rate variability (HRV) in a canine model of AF. During VNS, AF was induced in 9 of 9 experiments before, vs 3 of 9 experiments after administration of bepridil (P<0.01). During 350 ms atrial pacing, VNS shortened the right and left atrial monophasic action potentials at 90% repolarization (MAP90) by -31+/-8% and -22+/-12%, respectively, vs -10+/-13% and -6+/-8%, respectively, after bepridil (P<0.01, N=9). Bepridil prolonged the sinus cycle length, although it had no significant effect on the conduction time measured at 300 ms pacing. Statistically insignificant change was observed in the VNS-induced slowing of the sinus cycle length and in the VNS-induced increase in high frequency amplitude of HRV before (1.2+/-0.7 to 5.3+/-4.0 ms) vs after (1.7+/-0.8 to 5.4+/-2.3 ms) bepridil administration. CONCLUSIONS: Bepridil prevented the VNS-induced shortening of atrial MAP90 and suppressed the inducibility of AF during VNS in two-thirds of the experiments. As far as this study shows, it may be possible that inhibition of I(KAch) played a part in this antifibrillatory effect.
No takes yet. Share an insight, caveat, or question.
Iijima et al. (2010) studied Atrial fibrillation (n=9). Bepridil vs. Before administration of bepridil was evaluated on Inducibility of atrial fibrillation during vagal nerve stimulation (p=<0.01). Bepridil significantly suppressed the inducibility of atrial fibrillation during vagal nerve stimulation, reducing induction from 100% (9 of 9) to 33% (3 of 9) of experiments (P<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: